The Korean journal of internal medicine

  • 제27권1호
  • /
  • Pages.1-12
  • /
  • 2012
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

The Role of Optical Coherence Tomography in Coronary Intervention

  • 발행 : 2012.03.01
⟨ 이전 논문 다음 논문 ⟩

초록

Optical coherence tomography (OCT) is an optical analog of intravascular ultrasound (IVUS) that can be used to examine the coronary arteries and has 10-fold higher resolution than IVUS. Based on polarization properties, OCT can differentiate tissue characteristics (fibrous, calcified, or lipid-rich plaque) and identify thin-cap fibroatheroma. Because of the strong attenuation of light by blood, OCT systems required the removal of blood during OCT examinations. A recently developed frequency-domain OCT system has a faster frame rate and pullback speed, making the OCT procedure more user-friendly and not requiring proximal balloon occlusion. During percutaneous coronary intervention (PCI), OCT can provide detailed information (dissection, tissue prolapse, thrombi, and incomplete stent apposition [ISA]). At follow-up examinations after stent implantation, stent strut coverage and ISA can be assessed. Several OCT studies have demonstrated delayed neointimal coverage following drug-eluting stent (DES) implantation vs. bare metal stent (BMS) placement. While newer DESs promote more favorable vascular healing, the clinical implications remain unknown. Recent OCT studies have provided insights into restenotic tissue characteristics; DES restenotic morphologies differ from those with BMSs. OCT is a novel, promising imaging modality; with more in-depth assessments of its use, it may impact clinical outcomes in patients with symptomatic coronary artery disease.

키워드

참고문헌

  1. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science 1991;254:1178-1181. https://doi.org/10.1126/science.1957169
  2. Yamaguchi T, Terashima M, Akasaka T, et al. Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. Am J Cardiol 2008;101:562-567. https://doi.org/10.1016/j.amjcard.2007.09.116
  3. Kataiwa H, Tanaka A, Kitabata H, et al. Head to head comparison between the conventional balloon occlusion method and the non-occlusion method for optical coherence tomography. Int J Cardiol 2011;146:186-190. https://doi.org/10.1016/j.ijcard.2009.06.059
  4. Prati F, Cera M, Ramazzotti V, et al. From bench to bedside: a novel technique of acquiring OCT images. Circ J 2008;72:839-843. https://doi.org/10.1253/circj.72.839
  5. Barlis P, Schmitt JM. Current and future developments in intracoronary optical coherence tomography imaging. EuroIntervention 2009;4:529-533. https://doi.org/10.4244/EIJV4I4A89
  6. Takarada S, Imanishi T, Liu Y, et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv 2010;75:202-206. https://doi.org/10.1002/ccd.22273
  7. Imola F, Mallus MT, Ramazzotti V, et al. Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. Euro-Intervention 2010;6:575-581.
  8. Templin C, Meyer M, Muller MF, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy. Eur Heart J 2010;31:1792-1801. https://doi.org/10.1093/eurheartj/ehq168
  9. Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol 2002;39:604-609. https://doi.org/10.1016/S0735-1097(01)01799-5
  10. Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation 2002;106:1640-1645. https://doi.org/10.1161/01.CIR.0000029927.92825.F6
  11. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial plaque by optical coherence tomography. Am J Cardiol 2006;97:1172-1175. https://doi.org/10.1016/j.amjcard.2005.11.035
  12. Kume T, Akasaka T, Kawamoto T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography. Am Heart J 2006;152:755.e1-755.e4. https://doi.org/10.1016/j.ahj.2006.06.030
  13. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262-1275. https://doi.org/10.1161/01.ATV.20.5.1262
  14. Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation 2005;111:1551-1555. https://doi.org/10.1161/01.CIR.0000159354.43778.69
  15. Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 2007;50:933-939. https://doi.org/10.1016/j.jacc.2007.04.082
  16. Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006;97:1713-1717. https://doi.org/10.1016/j.amjcard.2006.01.031
  17. MacNeill BD, Jang IK, Bouma BE, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. J Am Coll Cardiol 2004;44:972-979. https://doi.org/10.1016/j.jacc.2004.05.066
  18. Manfrini O, Mont E, Leone O, et al. Sources of error and interpretation of plaque morphology by optical coherence tomography. Am J Cardiol 2006;98:156-159. https://doi.org/10.1016/j.amjcard.2006.01.097
  19. Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart 2009;95:1913-1919. https://doi.org/10.1136/hrt.2009.172072
  20. Kawamori H, Shite J, Shinke T, et al. The ability of optical coherence tomography to monitor percutaneous coronary intervention: detailed comparison with intravascular ultrasound. J Invasive Cardiol 2010;22:541-545.
  21. Terashima M, Rathore S, Suzuki Y, et al. Accuracy and reproducibility of stent-strut thickness determined by optical coherence tomography. J Invasive Cardiol 2009;21:602-605.
  22. Sawada T, Shite J, Negi N, et al. Factors that influence measurements and accurate evaluation of stent apposition by optical coherence tomography: assessment using a phantom model. Circ J 2009;73:1841-1847. https://doi.org/10.1253/circj.CJ-09-0113
  23. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J 2007;28:961-967. https://doi.org/10.1093/eurheartj/ehl413
  24. Katoh H, Shite J, Shinke T, et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. Circ J 2009;73:1033-1037. https://doi.org/10.1253/circj.CJ-08-0746
  25. Kim JS, Jang IK, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial. JACC Cardiovasc Interv 2009;2:1240-1247. https://doi.org/10.1016/j.jcin.2009.10.006
  26. Tanaka N, Terashima M, Rathore S, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis. JACC Cardiovasc Interv 2010;3:1074-1079. https://doi.org/10.1016/j.jcin.2010.08.006
  27. Guagliumi G, Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting. Catheter Cardiovasc Interv 2008;72:237-247. https://doi.org/10.1002/ccd.21606
  28. Terashima M, Ito T, Katoh O, et al. Relationship between stent apposition pattern and neointimal coverage after Sirolimuseluting stent implantation: analysis by optical coherence tomography (abstract). J Am Coll Cardiol 2006;47:13B.
  29. Ito T, Terashima M, Takeda Y, et al. Optical coherence tomographic analysis of neointimal stent coverage in Sirolimuseluting stent, compared with bare metal stent (abstract). J Am Coll Cardiol 2006;47:13B.
  30. Kim JS, Jang IK, Kim JS, et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents. Heart 2009;95:1907-1912. https://doi.org/10.1136/hrt.2009.167759
  31. Choi HH, Kim JS, Yoon DH, et al. Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography. Int J Cardiovasc Imaging 2011 Mar 26 [Epub]. http://dx.doi.org/10.1007/s10554-011-9849-7.
  32. Gutierrez-Chico JL, van Geuns RJ, Regar E, et al. Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial. Eur Heart J 2011;32:2454-2463. https://doi.org/10.1093/eurheartj/ehr182
  33. Takano M, Inami S, Jang IK, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimuseluting stent three months after implantation. Am J Cardiol 2007;99:1033-1038. https://doi.org/10.1016/j.amjcard.2006.11.068
  34. Kubo T, Imanishi T, Kitabata H, et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. JACC Cardiovasc Imaging 2008;1:475-484. https://doi.org/10.1016/j.jcmg.2008.03.012
  35. Guagliumi G, Costa MA, Sirbu V, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation 2011;123:274-281. https://doi.org/10.1161/CIRCULATIONAHA.110.963181
  36. Tahara S, Bezerra HG, Sirbu V, et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial. Heart 2010;96:1574-1578. https://doi.org/10.1136/hrt.2009.188037
  37. Guagliumi G, Musumeci G, Sirbu V, et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. JACC Cardiovasc Interv 2010;3:531-539.
  38. Her AY, Lee BK, Shim JM, et al. Neointimal coverage on drugeluting stent struts crossing side-branch vessels using optical coherence tomography. Am J Cardiol 2010;105:1565-1569. https://doi.org/10.1016/j.amjcard.2010.01.013
  39. Gutierrez-Chico JL, Regar E, Nuesch E, et al. Delayed coverage in malapposed and side-branch struts with respect to wellapposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography. Circulation 2011;124:612-623. https://doi.org/10.1161/CIRCULATIONAHA.110.014514
  40. Kume T, Akasaka T, Kawamoto T, et al. Visualization of neointima formation by optical coherence tomography. Int Heart J 2005;46:1133-1136. https://doi.org/10.1536/ihj.46.1133
  41. Habara M, Terashima M, Nasu K, et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study. Circ Cardiovasc Interv 2011;4:232-238. https://doi.org/10.1161/CIRCINTERVENTIONS.110.959999
  42. Gonzalo N, Serruys PW, Okamura T, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009;158:284-293. https://doi.org/10.1016/j.ahj.2009.06.004
  43. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010;75:961-963.

피인용 문헌

  1. Optical coherence tomography for presurgical margin assessment of non‐melanoma skin cancer – a practical approach vol.22, pp.8, 2013, https://doi.org/10.1111/exd.12196
  2. Research and Clinical Applications of Optical Coherence Tomography in Invasive Cardiology: A Review vol.10, pp.4, 2014, https://doi.org/10.2174/1573403x10666140604120753
  3. Investigation of Biodegradable Composite Coated Magnesium Alloy Using Optical Coherence Tomography vol.922, pp.None, 2014, https://doi.org/10.4028/www.scientific.net/amr.922.292
  4. Best selection in the priming and flashing solution and compensation mode used by FD-OCT. vol.84, pp.3, 2012, https://doi.org/10.4286/jjmi.84.361
  5. Understanding Left Main Disease: Will the Right SYNTAX Help Us EXCEL in (PRE)COMBAT? vol.8, pp.4, 2012, https://doi.org/10.1007/s12265-015-9635-3
  6. Detecting early stage osteoarthritis by optical coherence tomography? vol.20, pp.8, 2012, https://doi.org/10.3109/1354750x.2015.1130190
  7. Optical coherence tomography analysis of the stent strut and prediction of resolved strut malapposition at 3 months after 2nd-generation drug-eluting stent implantation vol.31, pp.8, 2012, https://doi.org/10.1007/s00380-015-0737-2
  8. Cardiac Allograft Vasculopathy: What We Know in 2016 vol.3, pp.3, 2016, https://doi.org/10.1007/s40472-016-0105-x
  9. Transluminal Attenuation Gradient for the Noninvasive Assessment of Functional Significance in Coronary Artery Stenoses vol.1, pp.3, 2016, https://doi.org/10.1515/jim-2016-0074
  10. Comparison between Preoperative Optical Coherence Tomography Findings of Carotid Artery Stenosis and Pathological Specimen of Removed Carotid Plaque: Case Report vol.11, pp.6, 2012, https://doi.org/10.5797/jnet.cr.2016-0098
  11. Clinical translation of handheld optical coherence tomography: practical considerations and recent advancements vol.22, pp.12, 2012, https://doi.org/10.1117/1.jbo.22.12.121715
  12. A Survey on Coronary Atherosclerotic Plaque Tissue Characterization in Intravascular Optical Coherence Tomography vol.20, pp.7, 2012, https://doi.org/10.1007/s11883-018-0736-8
  13. Intravascular imaging in neuroendovascular surgery: a brief review vol.40, pp.10, 2012, https://doi.org/10.1080/01616412.2018.1493972
  14. Vascular response and intrastent thrombus in the early phase after drug‐eluting versus bare‐metal stent implantation in patients with ST‐segment elevation myocardial infarction: A vol.2, pp.1, 2019, https://doi.org/10.1002/hsr2.105
  15. An automatic diagnostic system of coronary artery lesions in Kawasaki disease using intravascular optical coherence tomography imaging vol.13, pp.1, 2012, https://doi.org/10.1002/jbio.201900112
  16. Contrast-free optical coherence tomography:Systematic evaluation of non-contrast media for intravascular assessment vol.15, pp.8, 2012, https://doi.org/10.1371/journal.pone.0237588
  17. Current status of hybrid intravascular ultrasound and optical coherence tomography catheter for coronary imaging and percutaneous coronary intervention vol.77, pp.5, 2012, https://doi.org/10.1016/j.jjcc.2020.08.012
  18. Coronary Artery Calcification: From Cell to Stent-A Review vol.2, pp.2, 2012, https://doi.org/10.1177/26324636211013156
  19. Kounis syndrome secondary to nimesulide ingestion: a case report vol.73, pp.1, 2012, https://doi.org/10.1186/s43044-021-00233-x